休克年度会议和国际休克学会联合会第七届大会 2018

于由NBScience发布

休克年度会议和国际休克学会联合会第七届大会 2018

分类： 2018 麻醉学会议2018 心脏病学会议2018 会议2018 紧急会议2018 免疫学会议2018 神经病学会议2018 产科会议2018 疼痛会议2018 病理学会议2018 儿科会议2018 药理学会议2018 精神病学会议干细胞疗法

NBScience

合同研究机构

相关文章

干细胞疗法

Gene Therapy Products

Gene Therapy ProductsCollategeneANGESA gene therapy consisting of an intramuscular injection of plasmid (脱氧核糖核酸) coding for Hepatocyte Growth Factor (生长因子), intended to grow blood vessels, for the treatment of critical limb ischemia. Approved in Japan in 阅读更多…

干细胞疗法

Cell-Based Immunotherapy Products

Cell-Based Immunotherapy ProductsAbecmaBLUEBIRD BIOA chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed or refractory multiple myeloma. Approved by the US FDA in March 2021. Approved by Health Canada in May 2021. Approved by 阅读更多…

干细胞疗法

Tissue-Engineered Products

Tissue-Engineered ProductsAurixNUO THERAPEUTICSA biodynamic hematogel composed of platelet-rich plasma gel prepared from a small sample of a patient’s own platelets and plasma as a catalyst for healing indicated for the treatment of wounds. Marketed in 阅读更多…

干细胞疗法